Genomic Medicine
Studying how genomic sequencing can be integrated into clinical care for healthy individuals and families.
Associate Professor of Population Medicine
Associate Director, Precision Medicine Translational Research Center (PROMoTeR)
Harvard Pilgrim Health Care Institute • Harvard Medical School
Welcome! I am an Associate Professor of Population Medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School, and Associate Director of the Precision Medicine Translational Research Center (PROMoTeR). My research focuses on the clinical, behavioral, and economic impact of genomic medicine, with an emphasis on integrating genomic sequencing into health care in ways that improve patient outcomes and inform health policy.
PROMoTeR Center work continues to generate evidence that informs precision medicine policy and practice.
GLIMPSE is examining how newborn genomic sequencing gene lists and variant types influence implementation outcomes.
Current projects evaluate the clinical, behavioral, psychosocial, and economic impact of genomic testing in health care.
Studying how genomic sequencing can be integrated into clinical care for healthy individuals and families.
Evaluating value, costs, and policy implications of genomic technologies in health care settings.
Examining psychosocial, behavioral, and provider outcomes associated with clinical and consumer genomic testing.